PubMed COVID-19 Clinical Care

No abstract

CONCLUSIONS: Potential quality of life tradeoffs should be considered to a greater extent in future pandemic emergencies.

The economic landscape of the United Kingdom has been significantly shaped by the intertwined issues of Brexit, COVID-19, and their interconnected impacts. Despite the country's robust and diverse economy, the disruptions caused by Brexit and the

CONCLUSIONS: During COVID-19, a time where mental health and substance use-related problems have increased, programs need to re-evaluate current measures so that the negative effects of virtual care modalities can be reduced for this population

CONCLUSIONS: Doppler Ultrasound measurement may be a potential method for the management of high-risk pregnancies after asymptomatic/mild COVID-19 infection.

CONCLUSION: Both SARS-CoV-2 N-Ab automated assays are effective to evaluate humoral responses after various COVID-19 vaccines.

CONCLUSION: Women with high-risk pregnancies may experience COVID-19 anxiety, which may worsen their fear of childbirth. Psychosocial interventions focused on addressing COVID-19 anxiety are warranted for women with high-risk pregnancies in Turkey

CONCLUSIONS: Preventive measures and changes in treatment procedures were implemented according to the local COVID-19 situation. Some treatments were prolonged, e.g. because of lockdowns or patient's fear of contracting COVID-19 whilst receiving

CONCLUSIONS: Patients treated with abatacept showed an impaired humoral immune response to two doses of COVID-19 vaccine. The third vaccine dose has been demonstrated to be useful to induce a more robust antibody response to balance an impaired T

CONCLUSION: The administration of the drug does not require age-related dose adjustment and is well combined with basic therapy. The recommended regimen for the use of Mexidol: 14 days of 5 ml i/v or i/m, then taking the drug Mexidol FORTE 250 at a